Influenza A virus (IAV) possesses a segmented, negative-sense RNA genome comprising eight distinct viral RNA (vRNA) segments. These segments form ribonucleoprotein (RNP) complexes that are selectively ...
The technology, called the Viral-Engineered RNA-based Activation System (VERAS), hijacks the virus's own replication machinery to switch on reporter or therapeutic genes precisely in infected cells.